← Back to Search

Orthopedic immobilization for Muscle Atrophy (STAR Trial)

N/A

Waitlist Available

Research Sponsored by Texas Christian University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

Awards & highlights

STAR Trial Summary

This trial will test whether a new strength training protocol can help offset the negative effects of limb immobilization and help restore muscle function during rehabilitation.

Eligible Conditions

Muscle Atrophy

STAR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in EMG amplitude

Changes in action potential amplitude

Muscle Tissue

+3 more

STAR Trial Design

2Treatment groups

Experimental Treatment

Group I: Immobilization with unilateral trainingExperimental Treatment3 Interventions

The immobilization with unilateral training group will undergo arm immobilization for four with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body. The free (non-immobilzed) arm of this group will undergo heavy strength training twice per week throughout the immobilization period. The training will consist of unilateral dumbbell shoulder press and biceps curl.

Group II: Immobilization controlExperimental Treatment2 Interventions

The immobilization control group will undergo arm immobilization. Immobilization will be implemented with four weeks of muscle unloading with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Texas Christian UniversityLead Sponsor

27 Previous Clinical Trials

3,879 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are actively participating in this clinical trial?

"Affirmative. The clinicaltrials.gov website reveals that this trial, which was initially announced on August 13th 2021, is presently seeking participants. To complete the study, 20 individuals are needed to be recruited from 2 medical facilities."

Answered by AI

Are octogenarians able to join this experimental research?

"The target participants for this trial have to be between 18 and 35 years old."

Answered by AI

To whom does this clinical trial extend its invitation?

"This study seeks 20 subjects suffering from atrophy, aged 18-35 years old. Eligible candidates must have a BMI between 18 - 35 kg/m2, demonstrate right-hand dominance, agree to the specified immobilization protocols and strength training requirements of the trial, and forgo any other related exercise outside of its scope."

Answered by AI

Is this research project still onboarding participants?

"Clinicaltrials.gov confirms that this study is currently seeking participants, having been first unveiled on August 13th 2021 and last modified in October 14th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Strength Training Augmenting Rehabilitation

Joshua Carr 2021. "Strength Training Augmenting Rehabilitation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05097092.